Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. 29 Aug 2022  |  Global

    Advancements in miRNA: Technology Assessment

    Developments in miRNA sequencing and analysis are driving future growth potential in therapeutics and diagnostics

    Accelerated research around RNA-based therapeutics and diagnostics, accompanied by technology advancements in sequencing the human genome, has resulted in a better understanding of the role of miRNA in biological pathways, enhancing its potential in both therapeutics and diagnostics. The successful clinical validation of miRNA diagnostic tests has ...

    $4,950.00

    Special Price $4,207.50 save 15 %

  2. 26 Aug 2022  |  Global

    Global Hospital Operational Efficiency Solutions

    Visionary Perspectives for Medtech to Help Health Systems Improve Operational Efficiencies and Achieve Transformational Growth

    Hospitals are complex to manage and historically have faced various inefficiencies. After the COIVD-19 pandemic took a toll on hospitals’ financial resources and human capital, efficiency has become a major focus. Automated solutions are key to supporting already strained staff (reeling under shortages and burnout) and enhancing processes, which ...

    $2,450.00

    Special Price $2,082.50 save 15 %

  3. 23 Aug 2022  |  North America

    Global Bioanalytical Testing Services, 2021–2027

    Acquisition of Disruptive Technologies will be the Key to Driving Growth

    As the pharma market recovers from the debilitating impact of COVID-19 on the drug discovery and development pipelines, there is an increasing requirement for outsourcing services in the form of contract research organizations (CROs) and contract development & manufacturing organizations (CDMOs), which is likely to drive the already strong drug dev...

    $4,950.00

    Special Price $4,207.50 save 15 %

  4. 23 Aug 2022  |  North America

    Frost Radar™: US Liquid Biopsy, 2022

    A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

    The oncology space is maturing rapidly. With the arrival of blood-based assays for cancer screening and the emphasis on early detection, the liquid biopsy segment is seeing increased consolidation and high-impact acquisitions, such as Illumina and GRAIL, Exact Sciences and Thrive Earlier Detection, and Roche Foundation Medicine and Lexent Bio. Comp...

    $4,950.00

    Special Price $4,207.50 save 15 %

  5. 19 Aug 2022  |  North America

    Global Antibody Therapeutics Growth Opportunities

    The Evolution of Next-generation Immuno-oncology Therapies for Multiple Tumor Antigens is Poised to Drive Market Growth

    Market growth is likely to be fueled by the growing utilization of cost-effective and efficient continuous manufacturing processes and single-use bioreactors for production, which will also reduce the time between development and commercialization. Favorable regulatory reforms in emerging Asian countries are encouraging the manufacture and introduc...

    $2,450.00

    Special Price $2,082.50 save 15 %

  6. 19 Aug 2022  |  Global

    Digital Front Door and Patient Experience Solutions

    Healthcare is Being Propelled into a Consumer-centric Marketplace

    Frost & Sullivan has identified that the healthcare industry is witnessing massive disruption because of the digital revolution and competitive threats from new market entrants. COVID-19 exposed the strengths and weaknesses of healthcare organizations already striving to digitally transform their operations and create retail-like patient experi...

    $2,450.00

    Special Price $2,082.50 save 15 %

  7. 19 Aug 2022  |  North America

    Frost Radar™: Healthcare Data Analytics, 2022

    A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

    Healthcare organizations must be able to manage, analyze, and interpret data in order to identify strategic, tactical, and operational insights for decision making. This allows providers and payers to provide the best ways of delivering high-quality care. There has been a slow but steady change in the healthcare industry at the very core of its bus...

    $4,950.00

    Special Price $4,207.50 save 15 %

  8. 17 Aug 2022  |  Global

    Therapeutic Advances in Amyloidosis

    Research Efforts and Technology Developments through Partnerships and Collaborations will Push New Therapeutic Modalities into Treatment Regimens.

    Amyloidosis is a rare disease caused by the accumulation and the deposition of proteins such as immunoglobulin light-chain protein in AL amyloidosis and misfolded transthyretin (TTR) protein in ATTR amyloidosis. There are a few other types of amyloidosis as well, which are either a result of a preexisting condition or are not highly prevalent. Vari...

    $4,950.00

    Special Price $4,207.50 save 15 %

  9. 17 Aug 2022  |  North America

    Frost Radar™: Global Clinical Trial IT Solutions Market, 2022

    A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

    COVID-19 has accelerated the need for a faster, more accessible clinical trial process. During the height of the pandemic, in-person follow-ups for ongoing trials were replaced with hand-held devices that essentially built an ecosystem for home health care support services that can be easily leveraged to avoid or reduce participant dropout rates. ...

    $4,950.00

    Special Price $4,207.50 save 15 %

  10. 16 Aug 2022  |  North America

    Global Cell and Gene Therapy (CGT) Growth Opportunities

    The Shift to Prevalent Diseases and Allogeneic Cell Therapies Creates New Growth Opportunities in the CGT Value Chain

    This Frost & Sullivan study examines the global cell and gene therapy (CGT) market. It highlights revenue forecasts and key growth opportunities for CGT market participants based on the evolution of their business models and strategic approaches as well as investments and regulations. The study segments the market by product (cell therapy, gene-mod...

    $4,950.00

    Special Price $4,207.50 save 15 %